Skip to main navigation
Investor Relations
Press ReleasesCompany StatementsMedia ContactEmail Alerts
Events & PresentationsFinancialsStock InformationGovernanceResources
Compliance & Transparency
Our LocationsMedical Information
magnifying glass icon
Incyte Home
Main Nav
  • Our Company
  • What We Do
  • Culture & Careers
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
  • Our Company
    • Our Leadership
  • What We Do
    • Portfolio
    • Hematology and Oncology
      • Approved Therapies
      • HCP Resources
    • Inflammation and Autoimmunity
      • Approved Therapies
      • HCP Resources
    • Partnerships
  • Culture & Careers
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • Responsibility
    • Compliance & Transparency
Main Nav
  • magnifying glass icon
  • Our Company
    • magnifying glass icon
    • Our Leadership
  • What We Do
    • magnifying glass icon
    • Portfolio
    • Hematology and Oncology
    • Inflammation and Autoimmunity
    • Partnerships
  • Culture & Careers
    • magnifying glass icon
    • Open Positions
    • Incyte Involved
    • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
    • magnifying glass icon
    • Company Statements
    • Media Contact
    • Email Alerts
  • Investors
    • magnifying glass icon
    • Events & Presentations
    • Financials
    • Stock Information
    • Governance
    • Resources
  • Responsibility
    • magnifying glass icon
    • Compliance & Transparency
  • Contact Us
    • magnifying glass icon
    • Our Locations
    • Medical Information
  • United States
Home  >  Investors  >  events  >  event details  >  Incyte Investor Event- ESMO 2025

Event Details

Incyte International Locations

NORTH AMERICA— HEADQUARTERS

DENMARK

ITALY

SPAIN

UNITED KINGDOM

EUROPE— HEADQUARTERS

FINLAND

JAPAN

SWEDEN

AUSTRIA

FRANCE

THE NETHERLANDS

SWITZERLAND

CANADA

GERMANY

NORWAY

PORTUGAL

Close

  • Events
  • Corporate Presentations
  • Scientific Presentations

Incyte Investor Event- ESMO 2025

Oct 19, 2025 at 7:30 PM CEST

Click here for Webcast

Supporting Materials

Solid Tumor Spotlight: TGFβR2xPD-1 Bi-specific Antibody and KRAS G12D Inhibitor 5.1 MB

Investor Relations Inquiries

IR@incyte.com

Incyte Home
  • LinkedIn Icon
  • Twitter Icon
  • Instagram Icon
  • Facebook Icon
  • Youtube Icon
  • Our Company
  • Our Leadership
  • What We Do
  • Portfolio
  • Hematology and Oncology
  • Inflammation and Autoimmunity
  • Partnerships
  • Culture & Careers
  • Open Positions
  • Incyte Involved
  • Inclusion
  • Patient Resources
  • HCP Resources
  • Our Stories
  • News
  • Press Releases
  • Company Statements
  • Media Contact
  • Email Alerts
  • Investors
  • Events & Presentations
  • Financials
  • Stock Information
  • Governance
  • Resources
  • Responsibility
  • Compliance & Transparency
  • Contact Us
  • Our Locations
  • Medical Information
  • Legal Notice
  • Suppliers
  • Site Map
  • Privacy Policy
  • Cookie Policy
  • Consumer Health Data Privacy Policy
© 2012-2026 Incyte.